A small clinical trial showed a 2 to 10-fold increase in GH levels lasting up to 6 days after a single injection (Teichman et al., J Clin Endocrinol Metab 2006)
After 3 min of plasma treatment the signal at m/z = 229 was not anymore recorded giving glutathione sulfonic acid GSO 3 H as the only product
What we discovered when we searched the evidence Experimental data already provided the missing piece
In the comprehensive preclinical studies, MDR-001 has demonstrated excellent functional potency and selectivity, with favorable ADME properties and oral bioavailability, as well as desirable pharmacokinetics and tolerability
Read review Dihexa for Sleep Apnea Brain Fog OSA & hypoxemia, REM CA1 hippocampal loss (UC Irvine May 2025), Zepbound (tirzepatide) FDA approval Dec 2024 (SURMOUNT-OSA), NICE NG202, and the ~13 million UK adults estimated to have OSA
According to the site, Yucca lists pricing after intake once eligibility is confirmed